ArticleProstate international2022
Short course of dutasteride in treatment of a refractory category IIIB chronic prostatitis (A placebo-controlled study).
Ahmed Higazy et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it